메뉴 건너뛰기




Volumn 385, Issue 9975, 2015, Pages 1264-1266

Glaucoma treatment: By the highest level of evidence

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; LATANOPROST; ANTIHYPERTENSIVE AGENT; PROSTAGLANDIN F;

EID: 84926524604     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)62347-3     Document Type: Note
Times cited : (29)

References (13)
  • 2
    • 0020955893 scopus 로고
    • The epidemiology of open-angle glaucoma: A review
    • MC Leske The epidemiology of open-angle glaucoma: a review Am J Epidemiol 118 1983 166 191
    • (1983) Am J Epidemiol , vol.118 , pp. 166-191
    • Leske, M.C.1
  • 3
    • 0013956016 scopus 로고
    • Intra-ocular pressure, glaucoma and glaucoma suspects in a defined population
    • FC Hollows, PA Graham Intra-ocular pressure, glaucoma and glaucoma suspects in a defined population Br J Ophthalmol 50 1966 570 586
    • (1966) Br J Ophthalmol , vol.50 , pp. 570-586
    • Hollows, F.C.1    Graham, P.A.2
  • 4
    • 0023606854 scopus 로고
    • Ocular hypertension: A prospective twenty-year follow-up study
    • L Lundberg, K Wettrell, E Linnér Ocular hypertension: a prospective twenty-year follow-up study Acta Ophthalmol 65 1987 705 708
    • (1987) Acta Ophthalmol , vol.65 , pp. 705-708
    • Lundberg, L.1    Wettrell, K.2    Linnér, E.3
  • 5
    • 0024466719 scopus 로고
    • Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial
    • MA Kass, MO Gordon, MR Hoff et al. Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial Arch Ophthalmol 107 1989 1590 1598
    • (1989) Arch Ophthalmol , vol.107 , pp. 1590-1598
    • Kass, M.A.1    Gordon, M.O.2    Hoff, M.R.3
  • 6
    • 0026022304 scopus 로고
    • A comparison of treated and untreated glaucoma suspects
    • M Schulzer, SM Drance, GR Douglas A comparison of treated and untreated glaucoma suspects Ophthalmology 98 1991 301 307
    • (1991) Ophthalmology , vol.98 , pp. 301-307
    • Schulzer, M.1    Drance, S.M.2    Douglas, G.R.3
  • 7
    • 0024447343 scopus 로고
    • A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects
    • DL Epstein, JH Krug Jr, E Hertzmark, LL Remis, DJ Edelstein A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects Ophthalmology 96 1989 1460 1467
    • (1989) Ophthalmology , vol.96 , pp. 1460-1467
    • Epstein, D.L.1    Krug, Jr.J.H.2    Hertzmark, E.3    Remis, L.L.4    Edelstein, D.J.5
  • 8
    • 0033748355 scopus 로고    scopus 로고
    • Long-term effects of timolol therapy in ocular hypertension: A double-masked, randomised trial
    • A Heijl, B Bengtsson Long-term effects of timolol therapy in ocular hypertension: a double-masked, randomised trial Graefes Arch Clin Exp Ophthalmol 238 2000 877 883
    • (2000) Graefes Arch Clin Exp Ophthalmol , vol.238 , pp. 877-883
    • Heijl, A.1    Bengtsson, B.2
  • 9
    • 0032189334 scopus 로고    scopus 로고
    • The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma
    • Collaborative Normal-Tension Glaucoma Study Group
    • Collaborative Normal-Tension Glaucoma Study Group The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma Am J Ophthalmol 126 1998 498 505
    • (1998) Am J Ophthalmol , vol.126 , pp. 498-505
  • 10
    • 0036822851 scopus 로고    scopus 로고
    • Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial
    • Early Manifest Glaucoma Trial Group
    • A Heijl, MC Leske, B Bengtsson, L Hyman, B Bengtsson, M Hussein Early Manifest Glaucoma Trial Group Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial Arch Ophthalmol 120 2002 1268 1279
    • (2002) Arch Ophthalmol , vol.120 , pp. 1268-1279
    • Heijl, A.1    Leske, M.C.2    Bengtsson, B.3    Hyman, L.4    Bengtsson, B.5    Hussein, M.6
  • 11
    • 84926519653 scopus 로고    scopus 로고
    • Latanoprost for open-angle glaucoma (UKGTS): A randomised, multicentre, placebo-controlled trial
    • published online Dec 19.
    • DF Garway-Heath, DP Crabb, C Bunce et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial Lancet 2014 published online Dec 19. http://dx.doi.org/10.1016/S0140-6736(14)62111-5
    • (2014) Lancet
    • Garway-Heath, D.F.1    Crabb, D.P.2    Bunce, C.3
  • 12
    • 34848853772 scopus 로고    scopus 로고
    • Predictors of long-term progression in the early manifest glaucoma trial
    • EMGT Group
    • MC Leske, A Heijl, L Hyman, B Bengtsson, L Dong, Z Yang EMGT Group Predictors of long-term progression in the early manifest glaucoma trial Ophthalmology 114 2007 1965 1972
    • (2007) Ophthalmology , vol.114 , pp. 1965-1972
    • Leske, M.C.1    Heijl, A.2    Hyman, L.3    Bengtsson, B.4    Dong, L.5    Yang, Z.6
  • 13
    • 49449109010 scopus 로고    scopus 로고
    • Canadian Glaucoma Study 2: Risk factors for the progression of open-angle glaucoma
    • Canadian Glaucoma Study Group
    • BC Chauhan, FS Mikelberg, AG Balaszi, RP LeBlanc, MR Lesk, GE Trope Canadian Glaucoma Study Group Canadian Glaucoma Study 2: risk factors for the progression of open-angle glaucoma Arch Ophthalmol 126 2008 1030 1036
    • (2008) Arch Ophthalmol , vol.126 , pp. 1030-1036
    • Chauhan, B.C.1    Mikelberg, F.S.2    Balaszi, A.G.3    Leblanc, R.P.4    Lesk, M.R.5    Trope, G.E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.